Endoscopic Sleeve Gastroplasty for Obesity
Endoscopic Sleeve Gastroplasty (ESG) for the Treatment of Obesity
Recruiting
N/A
Interventional Study
Endoscopic Sleeve Gastroplasty
Obesity
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 150 (estimated)
- Sponsor
- The Methodist Hospital Research Institute · Other
Who this trial is looking for
This trial is looking for individuals seeking help with obesity through a procedure called endoscopic sleeve gastroplasty. Participants should have tried other weight loss methods without success.
Are You a Good Fit for This Trial?
You may be able to join if
- I have a body mass index (BMI) between 30 and 50
- I have struggled to lose weight or keep it off through diet and exercise
You may not be able to join if
- I am currently pregnant
- I smoke tobacco and have done so in the past 4 weeks
- I have active stomach ulcers or other serious stomach issues
- I have any type of stomach or bowel cancer
- I have a large hiatal hernia (larger than 5 cm)
- I have severe bleeding problems that cannot be fixed
- I have not been evaluated by a mental health professional for my psychiatric disorders
- I have previous endoscopic procedures that are not allowed
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
The purpose of this study is to evaluate endoscopic sleeve gastroplasty (ESG) for the treatment of obesity. The ESG procedure is an U.S. Food and Drug Administration (FDA) approved procedure for the treatment of obesity - patients with a body mass index (BMI) 30-50 kg/m2. This procedure is FDA approved; however, Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients with BMI 30 to 50 kg/m2
* Patients that have been unable able to lose weight, or maintain weight loss, through more conservative measures (i.e., lifestyle interventions including diet and exercise) per the FDA approval for the Apollo ESG device. Lifestyle intervention…
Contacts